We are live on ! Find out more
BATRK icon

Atlanta Braves Holdings Series B

180 hedge funds and large institutions have $830M invested in Atlanta Braves Holdings Series B in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 45 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

11% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 45

2% more funds holding

Funds holding: 177180 (+3)

0.35% more ownership

Funds ownership: 74.92%75.27% (+0.35%)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

1% less capital invested

Capital invested by funds: $836M → $830M (-$6.47M)

Holders
180
Holders Change
+3
Holders Change %
+1.69%
% of All Funds
3.95%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.18%
New
17
Increased
50
Reduced
45
Closed
14
Calls
$413K
Puts
Net Calls
+$413K
Net Calls Change
-$54K
Name Holding Trade Value Shares
Change
Change in
Stake
PWAM
1
Park West Asset Management
California
$74.5M +$2.7M +95,547 +4%
BlackRock
2
BlackRock
New York
$69.7M +$2.87M +101,814 +4%
CI Investments Inc
3
CI Investments Inc
Ontario, Canada
$55.7M +$2.81M +99,600 +5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$52.5M +$952K +33,737 +2%
TCM
5
Tensile Capital Management
California
$48.5M -$2.82M -100,000 -5%
GI
6
GAMCO Investors
Connecticut
$47M -$1.24M -43,944 -3%
MCM
7
Mason Capital Management
New York
$37.8M
SCM
8
Shapiro Capital Management
Georgia
$34.8M +$9.12M +323,150 +35%
Renaissance Technologies
9
Renaissance Technologies
New York
$30.8M -$22.4K -795 -0.1%
GF
10
Gabelli Funds
New York
$26.5M +$84.6K +3,000 +0.3%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$24M -$375K -13,300 -2%
LCM
12
Lionstone Capital Management
New York
$20.4M
State Street
13
State Street
Massachusetts
$20.2M +$284K +10,060 +1%
Principal Financial Group
14
Principal Financial Group
Iowa
$20.2M +$705 +25 +0%
GGHC
15
Gilder Gagnon Howe & Co
New York
$16.6M -$292K -10,335 -2%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$14.4M +$2.03M +72,134 +16%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$14.1M -$811K -28,735 -5%
ACM
18
Atika Capital Management
New York
$12.5M +$1.55M +54,836 +14%
Northern Trust
19
Northern Trust
Illinois
$12.4M +$439K +15,558 +4%
EAM
20
Eagle Asset Management
Florida
$11.3M -$1.48M -52,366 -11%
N
21
Nuveen
North Carolina
$10.7M +$28K +991 +0.3%
OFCM
22
One Fin Capital Management
California
$10.7M
Norges Bank
23
Norges Bank
Norway
$9.32M +$3.97M +140,751 +72%
PCR
24
Potrero Capital Research
California
$8.78M
ClearBridge Investments
25
ClearBridge Investments
New York
$8.49M -$4.51M -159,996 -34%

BATRK Hedge Fund Activity: Q3 2019 in Review

180 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Atlanta Braves Holdings Series B (BATRK) for Q3 2019, worth a combined $830M — down 0.77% from $836M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BATRK positions and 14 closed out — a net gain of 3 holders — while 50 added to existing stakes and 45 trimmed.

The largest buyer was Shapiro Capital Management, adding an estimated $9.12M. The largest seller was Oaktree Capital Management, exiting entirely with an estimated $5.11M sold.

  • 180 institutional investors held Atlanta Braves Holdings Series B (BATRK) as of Q3 2019, up from 177 in Q2 2019.
  • Funds reported $830M of Atlanta Braves Holdings Series B stock for Q3 2019, down 0.77% quarter-over-quarter.
  • 17 funds opened new Atlanta Braves Holdings Series B positions in Q3 2019 and 14 closed out, a net change of +3 holders.
  • The largest Atlanta Braves Holdings Series B buyer in Q3 2019 was Shapiro Capital Management, an estimated $9.12M added.
  • The largest Atlanta Braves Holdings Series B seller in Q3 2019 was Oaktree Capital Management, an estimated $5.11M sold.

Based on aggregated 13F filings for Q3 2019.